Health ❯Healthcare ❯Chronic Diseases ❯Diabetes

Type 2 Diabetes

Study Highlights Benefits and Risks of Popular Weight-Loss Drugs

Ozempic May Lower Alzheimer's Risk in Type 2 Diabetics, Study Finds

Novo Nordisk's Oral Semaglutide Shows 14% Reduction in Heart Risks

Semaglutide Shows Promise in Reducing Opioid Overdose Risk, Study Finds

New Research Highlights Key Factors for Effective Weight Loss with GLP-1 Drugs

Type 2 Diabetes Drug Shows Potential to Lower Dementia Risk by 35%

NHS 'Soup and Shake' Diet Shows Promise in Reversing Type 2 Diabetes

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks

Semaglutide Drugs Show Potential Beyond Weight Loss

Ozempic's Expanding Role: Beyond Diabetes and Weight Loss